AVXL - Originally intended to report data from Phase 2A Alzheimer Disease trial in September. Moved that up to July 22nd at a conference. Probably a good sign. Companies probably wouldn't attend a conference in order to report bad news. This Company has a lot going for it, IMO. http://www.anavex.com/?post_type=news&p=1478
Lovely chart - 52 week high today - High volume - 79,000,000 O/S - ~150,000,000 fully diluted
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.